🇺🇸 FDA
Patent

US 6893869

Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule

expired A61KA61K2239/31A61K2239/38

Quick answer

US patent 6893869 (Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue May 17 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K39/00, A61K40/00